Indication
Xerostomia
Xerostomia is the subjective sensation of oral dryness, which typically affects the oral cavity and oropharyngeal structures. Read more about Xerostomia
17 drugs 16 manufacturers
Drugs that treat it
Common Xerostomia therapies.
PILOCARPINE HCL
PILOCARPINE HCL
PILOCARPINE HCL
PILOCARPINE HCL
PILOCARPINE HCL
PILOCARPINE HCL
PILOCARPINE HCL
PILOCARPINE HCL
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonXerostomia is the subjective sensation of oral dryness, which typically affects the oral cavity and oropharyngeal structures.
It most commonly arises secondary to anticholinergic or other xerogenic medications, autoimmune disorders such as Sjögren syndrome, or radiation therapy to the head and neck.
Pathophysiologically, the condition often stems from salivary gland hypofunction and diminished salivary flow, although it can also occur secondary to qualitative alterations in salivary composition or mucosal hydration without measurable volume loss.
Clinical manifestations include difficulty with mastication, speech, and deglutition, often accompanied by altered taste perception, oral burning, and an increased susceptibility to dental caries and oral mucosal infections.
- nih.gov
Xerostomia is the subjective sensation of oral dryness, which typically affects the oral cavity and oropharyngeal structures It most commonly arises secondary to anticholinergic or other xerogenic medications, autoimmune disorders such as Sjögren syndrome, or radiation therapy to the head and neck Clinical manifestations include difficulty with mastication, speech, and deglutition, often accompanied by altered taste perception, oral burning, and an increased susceptibility to dental caries and o...
- nih.gov
Xerostomia is the subjective sensation of oral dryness, which typically affects the oral cavity and oropharyngeal structures
- nih.gov
It most commonly arises secondary to anticholinergic or other xerogenic medications, autoimmune disorders such as Sjögren syndrome, or radiation therapy to the head and neck
- nih.gov
Pathophysiologically, the condition often stems from salivary gland hypofunction and diminished salivary flow, although it can also occur secondary to qualitative alterations in salivary composition or mucosal hydration without measurable volume loss
- nih.gov
Pathophysiologically, the condition often stems from salivary gland hypofunction and diminished salivary flow, although it can also occur secondary to qualitative alterations in salivary composition or mucosal hydration without measurable volume loss Clinical manifestations include difficulty with mastication, speech, and deglutition, often accompanied by altered taste perception, oral burning, and an increased susceptibility to dental caries and oral mucosal infections
- nih.gov
Clinical manifestations include difficulty with mastication, speech, and deglutition, often accompanied by altered taste perception, oral burning, and an increased susceptibility to dental caries and oral mucosal infections
Personalize your experience
Follow Xerostomia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.